Keryx on SPi NewsFollow our SPi News RSS Feed for keryx

Featured keryx News

[13 Sep 2017] Keryx Biopharmaceuticals Announces Changes to its Board of Directors

[05 Sep 2017] Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017

[01 May 2017] Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D Plans

[08 Mar 2017] Keryx Biopharmaceuticals Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Auryxia® (ferric citrate) Tablets

[01 Mar 2017] Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results

[23 Feb 2017] Keryx Biopharmaceuticals to Webcast its Presentations at Two Investor Conferences in March 2017

[22 Dec 2016] Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 35th Annual Healthcare Conference on January 11, 2017

[18 Nov 2016] Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney Week

[09 Nov 2016] Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia® (ferric citrate)

[09 Nov 2016] Keryx Biopharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update

[03 Nov 2016] Keryx Biopharmaceuticals to Webcast its Presentation at Stifel’s 2016 Healthcare Conference on November 15

[14 Oct 2016] Keryx Biopharmaceuticals Announces Presentations of Data at the American Society of Nephrology Kidney Week 2016 Annual Meeting

[28 Sep 2016] October 3rd Deadline in Lawsuit for Investors in shares of Keryx Biopharmaceuticals (NASDAQ:KERX) announced by Shareholders Foundation

[21 Sep 2016] Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare Conference

[17 Sep 2016] KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX

[16 Sep 2016] KERYX ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important October 3 Deadline in Class Action

[01 Sep 2016] Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare Conferences

[31 Aug 2016] EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX

[31 Aug 2016] Lawsuit for Investors in shares of Keryx Biopharmaceuticals (NASDAQ:KERX) announced by Shareholders Foundation

[06 Aug 2016] KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX

[05 Aug 2016] SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Keryx Biopharmaceuticals, Inc. and Certain Officers – KERX

[04 Aug 2016] KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX

[01 Aug 2016] Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial Results

[27 Jun 2016] Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy

[21 Jun 2016] Keryx Biopharmaceuticals Appoints Two New Board Members

[14 Jun 2016] Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21

[28 Apr 2016] Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results

[01 Apr 2016] Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors

[01 Mar 2016] Keryx Biopharmaceuticals to Present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7

[25 Feb 2016] Keryx Biopharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results

[01 Dec 2015] Keryx Biopharmaceuticals Announces Webcast of Presentation at Oppenheimer's 26th Annual Healthcare Conference

[29 Oct 2015] Keryx Biopharmaceuticals Announces Third Quarter 2015 Financial Results

[05 Aug 2015] Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results

[27 Jul 2015] Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer

[16 Jun 2015] Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015

[30 Apr 2015] Keryx Biopharmaceuticals Completes Transition of CEO Role to Greg Madison

[23 Apr 2015] Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer

[04 Mar 2015] Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology

[25 Feb 2015] Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences

[08 Jan 2015] Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch

[22 Dec 2014] Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA(TM) (ferric citrate) Tablets in the United States

[08 Dec 2014] Keryx Biopharmaceuticals, Inc. to Present at the Oppenheimer & Co. Inc. 25th Annual Healthcare Conference

[30 Oct 2014] Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2014 Financial Results

[05 Sep 2014] Keryx Biopharmaceuticals, Inc. to Present at the Rodman & Renshaw 16th Annual Global Investment Conference

[07 Aug 2014] Keryx Biopharmaceuticals, Inc. Announces Second Quarter and Six Month 2014 Financial Results

[05 Aug 2014] Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2014 Financial Results

[30 Jun 2014] Health Care Sector Equities Technical Coverage -- Research on Keryx Biopharma, Thoratec, Unilife, and VIVUS

[18 Jun 2014] Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate

[18 Jun 2014] Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate

[17 Jun 2014] Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers